Technical Analysis for PXMD - PaxMedica, Inc.

Grade Last Price % Change Price Change
D 2.70 -12.34% -0.38
PXMD closed down 12.34 percent on Thursday, January 26, 2023, on 55 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup -12.34%
Upper Bollinger Band Walk Strength -12.34%
Inside Day Range Contraction -12.34%
Wide Bands Range Expansion -12.34%
Upper Bollinger Band Touch Strength -12.34%
Expansion Breakout Bullish Swing Setup -21.97%
Pocket Pivot Bullish Swing Setup -21.97%
Wide Range Bar Range Expansion -21.97%
Stochastic Reached Overbought Strength -21.97%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR about 7 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Fell Below 10 DMA about 12 hours ago
10 DMA Support about 13 hours ago
Down 5% about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PaxMedica, Inc. Description

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disorders Chronic Condition Drug Therapies Autism Spectrum Disorder Chronic Fatigue Syndrome

Is PXMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.48
52 Week Low 1.36
Average Volume 1,131,801
200-Day Moving Average 0.00
50-Day Moving Average 2.23
20-Day Moving Average 2.51
10-Day Moving Average 2.84
Average True Range 0.45
RSI 53.49
ADX 38.08
+DI 30.54
-DI 13.81
Chandelier Exit (Long, 3 ATRs) 2.39
Chandelier Exit (Short, 3 ATRs) 2.72
Upper Bollinger Bands 3.32
Lower Bollinger Band 1.69
Percent B (%b) 0.62
BandWidth 64.80
MACD Line 0.25
MACD Signal Line 0.20
MACD Histogram 0.0518
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.60
Resistance 3 (R3) 3.65 3.40 3.45
Resistance 2 (R2) 3.40 3.17 3.37 3.40
Resistance 1 (R1) 3.05 3.03 2.92 3.00 3.35
Pivot Point 2.80 2.80 2.74 2.77 2.80
Support 1 (S1) 2.45 2.57 2.33 2.40 2.05
Support 2 (S2) 2.20 2.43 2.18 2.00
Support 3 (S3) 1.85 2.20 1.95
Support 4 (S4) 1.80